Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 2
2018 4
2019 3
2020 3
2021 2
2022 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
The safety and efficacy of durvalumab consolidation therapy in the management of patients with stage III non-small-cell lung cancer and preexisting interstitial lung disease.
Kawanaka Y, Yasuda Y, Tanizaki J, Iwashima D, Nonagase Y, Uemasu K, Hirayama Y, Ogura M, Ozaki T, Takahashi KI. Kawanaka Y, et al. Among authors: uemasu k. Respir Investig. 2022 Sep;60(5):667-673. doi: 10.1016/j.resinv.2022.05.004. Epub 2022 Jun 18. Respir Investig. 2022. PMID: 35725721
Low serum free light chain is associated with risk of COPD exacerbation.
Tanimura K, Sato S, Sato A, Tanabe N, Hasegawa K, Uemasu K, Hamakawa Y, Hirai T, Muro S. Tanimura K, et al. Among authors: uemasu k. ERJ Open Res. 2020 Jul 6;6(2):00288-2019. doi: 10.1183/23120541.00288-2019. eCollection 2020 Apr. ERJ Open Res. 2020. PMID: 32665945 Free PMC article.
Complementary regional heterogeneity information from COPD patients obtained using oxygen-enhanced MRI and chest CT.
Fuseya Y, Muro S, Sato S, Tanabe N, Sato A, Tanimura K, Hasegawa K, Uemasu K, Kubo T, Kido A, Fujimoto K, Fushimi Y, Kusahara H, Sakashita N, Ohno Y, Togashi K, Mishima M, Hirai T. Fuseya Y, et al. Among authors: uemasu k. PLoS One. 2018 Aug 30;13(8):e0203273. doi: 10.1371/journal.pone.0203273. eCollection 2018. PLoS One. 2018. PMID: 30161221 Free PMC article.
Chronic Kidney Disease Predicts Survival in Patients with Idiopathic Pulmonary Fibrosis.
Ikezoe K, Handa T, Tanizawa K, Yokoi H, Kubo T, Aihara K, Sokai A, Nakatsuka Y, Hashimoto S, Uemasu K, Sato S, Muro S, Nagai S, Yanagita M, Chin K, Hirai T, Taguchi Y, Mishima M. Ikezoe K, et al. Among authors: uemasu k. Respiration. 2017;94(4):346-354. doi: 10.1159/000478787. Epub 2017 Jul 21. Respiration. 2017. PMID: 28728146 Free article.
Alectinib Resistance in ALK-Rearranged Lung Cancer by Dual Salvage Signaling in a Clinically Paired Resistance Model.
Tsuji T, Ozasa H, Aoki W, Aburaya S, Funazo T, Furugaki K, Yoshimura Y, Ajimizu H, Okutani R, Yasuda Y, Nomizo T, Uemasu K, Hasegawa K, Yoshida H, Yagi Y, Nagai H, Sakamori Y, Ueda M, Hirai T, Kim YH. Tsuji T, et al. Among authors: uemasu k. Mol Cancer Res. 2019 Jan;17(1):212-224. doi: 10.1158/1541-7786.MCR-18-0325. Epub 2018 Aug 31. Mol Cancer Res. 2019. PMID: 30171175
19 results